kwhempright kwhempleft

Kannaway Achieves Largest Revenue Month in Company History for Japan Division in May 2022

Jun 14, 2022 Kannaway Achieves Largest Revenue Month in Company History for Japan Division in May 2022

SAN DIEGO, CA, June X, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that in May its subsidiary Kannaway® has achieved its largest revenue month in the company’s history for its Japan division.

According to one of the most recent industry reports, Japan’s CBD market is projected to become the second-largest CBD market in Asia, growing to about $1.9 billion USD by 2024.

“We are proud of our team in Japan for this achievement and for breaking its sales records every month so far this year,” said Medical Marijuana, Inc. CEO Blake Schroeder. “We are confident that the demand for CBD products in Japan will continue to expand as the Japan CBD market is currently seeing a yearly growth rate of nearly 100% YOY.”


Back to the list of news

Recent news
HOT NEW Product Promo for August!
Here’s a scorching discount and BV booster for August!
Value Pack Cash Bonus Bump
Nasdaq publishes Kannaway CBD opportunity article
The perfect PROMO to finish July strong!
Get Sizzling Summer Savings on Kannaway DELTΔ-8